According to Zhito Finance APP, Shanghai Kaibao (300039.SZ) announced that the company and its wholly-owned subsidiary Shanghai Kaibao Xinyi (Xinxiang) Pharmaceutical Co., Ltd. (referred to as "Xinyi Pharmaceutical") have a total of 91 pharmaceuticals included in the national medical insurance directory, including 50 in category A and 41 in category B. This mainly involves 3 exclusive varieties (the company's product Phlegm Heat Clearing Injection, Phlegm Heat Clearing Capsules, and the subsidiary's product Qi Shen Capsules), and 1 exclusive dosage form (the company's product Dysophylline Capsules) continues to be included in the "National Medical Insurance Directory (2024)".